Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Management of patients coinfected with HCV and HIV: A close look at the role for direct-acting antivirals
Susanna Naggie,
Mark S. Sulkowski
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
74
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of patients coinfected with HCV and HIV: A close look at the role for direct-acting antivirals'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Hepacivirus
100%
Antiviral Agents
92%
Interferons
79%
HIV
74%
Sustained Virologic Response
58%
Ribavirin
48%
Drug Interactions
42%
Liver Diseases
36%
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
33%
telaprevir
32%
Virus Diseases
31%
Chronic Hepatitis C
22%
Drug Users
22%
Protease Inhibitors
22%
Sexual and Gender Minorities
22%
Coinfection
20%
Drug-Related Side Effects and Adverse Reactions
19%
Disease Progression
17%
Cause of Death
17%
Genotype
15%
Education
13%
Morbidity
12%
Injections
12%
Mortality
10%
Infections
10%
Population
8%
Therapeutics
7%